FABBS tracks funding and science policy issues of interest to our scientists and communicates this information via the website and news highlights. You are encouraged to sign-up to receive news highlights via email.
News from FABBS and the FABBS Foundation
- Congressional Committees Begin Process to Set Agency Spending Levels »
Now that the new Congress is in place, committee assignments are complete (or almost complete), and Congress has had a chance to review the President’s proposed budget for FY 2016 (contact FABBS for details or questions regarding their analysis), House and Senate committees, including appropriations committees that will create the spending bills for federal agencies, are beginning to hold hearings with agency directors to discuss the specifics of their proposed budgets. This will occur over the next month or so. Science advocates, including FABBS, track these closely to learn more about committee leaders’ plans, interests, and concerns with the research agencies who fund our sciences.
- Behavioral Science Research and Cybersecurity »
The U. S. House of Representatives put new policies in place to strengthen cybersecurity; new policies aim to improve staff training, among other measures. According to Roll Call, the Senate sergeant-at-arms office recognized the importance of the human side of the cybersecurity problem: “Although technical solutions… go a long way toward protecting online information, end users are still the first and most effective line of defense.” In response to the many highly publicized attacks on the financial and health sectors, among others, efforts are underway to improve both the technological and human sides of the problem.
- Neuropsychologist O'Bryant Presented with Early Career Award »
Alzheimer's Disease (AD) affects over 5 million Americans, and every 68 seconds another person develops the disease. But by the time family members and even doctors recognize the symptoms, the brain disease has progressed to a point that is severe and difficult to treat. What if AD patients could be identified and treated earlier and more easily? Soon that will be a reality, thanks to a blood test developed by FABBS Foundation Early Career Impact Award winner from the National Academy of Neuropsychology, Dr. Sid O'Bryant at the University of North Texas Health Science Center, and his colleagues. “This test can detect with over 90% accuracy who has the disease, and it provides a way for primary care physicians to screen for possible Alzheimer’s,” he explains. This is a big change, because AD has typically been diagnosed by specialists at Alzheimer’s clinics, which are few and far between.
Interested in learning more? A full listing of our news is available here.